Sucampo Pharma (SCMP) Income Statement

Click line-items for a historical chart and %

Research and development revenue	3.17M
Product royalty revenue	20.77M
Co-promotion revenue
Contract and collaboration revenue	2.38M
Total revenues	57.87M
Research and development	9.98M
General and administrative	11.06M
Selling and marketing	696K
Total operating expenses	44.61M
Income (loss) from operations	13.27M
Interest income	31K
Interest expense	-5.9M
Other income (expense), net	8.1M
Total non-operating income (expense), net	2.23M
Income (loss) before income taxes	15.5M
Income tax benefit (provision)	-7.41M
Net income (loss)	8.09M
Basic net income (loss) per share	0.19
Diluted net income (loss) per share	0.19
Weighted average common shares outstanding - basic	42.81M
Weighted average common shares outstanding - diluted	43.44M
Net income (loss)	8.09M
Unrealized gain (loss) on investments, net of tax effect	0
Foreign currency translation
Comprehensive income (loss)	12.74M

Entities mentioned with SCMP

View All Entities